AZ1495 targets interleukin-1 receptor-associated kinases, which play a crucial role in the signaling pathways of immune response and inflammation. It targets CLK1, CLK2, CLK4, haspin, IRAK1, and IRAK4.
AZ1495 serves as an IRAK inhibitor in studies related to understanding inflammatory signaling pathways and immune response modulation.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.